fbpx
usa-map usa-map

Learn more about the dangers of smurfing here

Learn more

Kansas’ NPLEx Technology A Success In 2014

National Association of Drug Diversion Investigators
January 20, 2015

LUTHERVILLE, Md., Jan. 20, 2015 /PRNewswire/ — The National Association of Drug Diversion Investigators (NADDI) today applauded the significant results achieved by Kansas’ real-time, stop-sale pseudoephedrine (PSE) tracking system in 2014.

The National Precursor Log Exchange (NPLEx) system automatically blocks unlawful PSE purchases at the point of sale and helps flag potential meth offenders for law enforcement. Police officers and narcotics agents often set up NPLEx “watch lists” that notify them via email when a meth suspect attempts to make a PSE purchase. The year-end NPLEx data show that in 2014, the technology blocked the sale of more than 14,000 boxes of medicine containing pseudoephedrine— keeping more than 38,000 grams out of the hands of potential meth criminals in Kansas.

Additionally, Kansas sold 7.62 percent fewer boxes of PSE compared to 2013. The number of individual purchasers was further reduced by 7.06 percent.

“NPLEx has continued to be a vital tool for pharmacists and law enforcement professionals in Kansas,” said Charles F. Cichon, executive director of NADDI. “Preventing the illegal sale of pseudoephedrine and stopping meth crime at its source is the goal of NPLEx and Kansas was a great example of what the system can do. NPLEx has allowed regular consumers to continue to keep their access to pseudoephedrine while preventing criminals from misusing it.”

About NADDI

The National Association of Drug Diversion Investigators (NADDI) is a non-profit 501(c)(3) organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies, and pharmaceutical manufacturers in the investigation and prevention of prescription drug abuse and diversion. NADDI also sponsors and conducts specialized educational seminars and conferences.

SOURCE National Association of Drug Diversion Investigators